Valuation: MicroPort Scientific Corporation

Market Cap 1.49B 11.66B 1.33B 1.23B 1.12B 2.12B 144B 2.13B 14.86B 5.82B 73.32B 5.58B 5.46B 235B P/E 2026 *
17.1x
P/E 2027 * 16.6x
Enterprise Value 2.23B 17.47B 1.99B 1.85B 1.68B 3.18B 215B 3.19B 22.26B 8.72B 110B 8.36B 8.18B 352B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.63x
Free-Float
61.84%
Yield 2026 *
-
Yield 2027 * -
08-31 MicroPort Scientific Corporation Delays Earnings Results Release for the Six Months Ended June 30, 2026 CI
08-28 MicroPort Scientific Corporation Announces Board and Committee Changes, Effective August 28, 2026 CI
08-13 MicroPort Scientific Expects to Record Loss in H1 MT
08-12 MicroPort Scientific Corporation Provides Preliminary Consolidated Earnings Guidance for the Six Months Ended 30 June 2026 CI
07-16 MicroPort Scientific Unit Eyes Sale of Controlling Stake in Orthopedics Business MT
06-30 MicroPort Scientific Corporation Appoints Dr. Yingyao Chen as an Independent Non-executive Director CI
05-27 Microport Scientific Corporation Announces Appointment of Greg Holman to Chief Commercial Officer CI
05-21 Bayzed Health Unit Partners With MicroPort Units on Smart Healthcare Services MT
05-20 Bayzed Medical Investment Group Company Limited, Wholly Owned Subsidiary of Bayzed Health Group Inc Enters into Strategic Cooperation Agreements with Shanghai Weichuang Weilian Weitong Health Management Co., Ltd. and Shanghai Mingyue Medical Technology Co., Ltd, Subsidiaries of MicroPort Scientific Corporation CI
04-30 MicroPort Scientific Corporation Auditor Raises 'Going Concern' Doubt CI
04-29 Microport Scientific says qtrly net profit attributable for Shanghai Microport Endovascular Medtech (Group) RMB154.8 mln RE
04-08 Microport Cardioflow Medtech Corporation and Microport Scientific Corporation Enter Distribution Agreements for International Markets CI
04-02 Nomura Adjusts MicroPort Scientific's Price Target to HK$9.85 From HK$8.81, Keeps at Neutral MT
1 day-2.64%
3 months-10.00%
6 months-32.80%
Current year-43.85%
Current year 5.83
Extreme 5.83
14.16
1 year 5.83
Extreme 5.83
14.16
3 years 4.46
Extreme 4.46
16.28
5 years 4.46
Extreme 4.46
44.2
10 years 4.46
Extreme 4.46
72.85
Manager TitleAgeSince
Chief Executive Officer 51 27/06/2025
Chief Executive Officer 63 20/09/2012
Director of Finance/CFO 51 01/09/2012
Director TitleAgeSince
Chairman 63 06/10/2011
Director/Board Member 62 03/09/2010
Director/Board Member 69 03/09/2010
Date Insider Type Main position Quantity % Market Cap. Importance
07/01/26 Other

Chief Executive Officer

400,000 0.0209%
05/01/26 Other

Chief Executive Officer

500,000 0.0261%
02/01/26 Other

Chief Executive Officer

1,400,000 0.0732%
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%-.--%-59.01%-47.54% 1.48B
+0.93%+0.49%+23.07%+32.63% 243B
+1.08%+2.69%+7.50%+0.66% 155B
+2.06%+8.17%-4.46%+43.96% 150B
+1.64%+0.31%-56.08%-18.45% 61.93B
+1.15%+0.07%+13.33%+16.89% 49.12B
+2.30%+3.38%-19.28%-16.69% 48.78B
+1.41%+1.65%+21.72%+53.25% 48.08B
+3.96%+8.34%-0.78%+38.92% 47.95B
+1.08%+2.01%+31.27%+62.47% 42.62B
Average +1.30%+2.24%-4.27%+16.61% 84.75B
Weighted average by Cap. +1.50%+2.74%+5.42%+24.21%

Financials

2026 *2027 *
Net sales 1.17B 9.19B 1.05B 973M 885M 1.67B 113B 1.68B 11.71B 4.59B 57.8B 4.4B 4.3B 185B 1.34B 10.5B 1.2B 1.11B 1.01B 1.91B 129B 1.92B 13.38B 5.24B 66.02B 5.02B 4.91B 212B
Net income 84.77M 665M 75.71M 70.43M 64.06M 121M 8.2B 121M 848M 332M 4.18B 318M 311M 13.42B 89.63M 703M 80.05M 74.46M 67.73M 128M 8.67B 128M 896M 351M 4.42B 337M 329M 14.19B
Net Debt 740M 5.81B 661M 615M 559M 1.06B 71.62B 1.06B 7.4B 2.9B 36.51B 2.78B 2.72B 117B 693M 5.44B 619M 575M 523M 988M 67.04B 993M 6.93B 2.71B 34.18B 2.6B 2.54B 110B
Projected Income Statement - Annual - MicroPort Scientific Corporation
Logo MicroPort Scientific Corporation
Microport Scientific Corp Microport Scientific Corp is an investment holding company mainly engaged in the sale, manufacture, research and development (R&D) of medical devices. The Company operates in eight segments. The Cardiovascular Devices Business segment includes implantable devices and access devices. The Orthopedics Devices Business segment includes reconstructive joints and spine products. The Cardiac Rhythm Management (CRM) Business segment includes pacemakers and defibrillators. The Endovascular and Peripheral Vascular Devices Business segment includes L-REBOA aortic occlusion balloons. The Neurovascular Devices Business segment includes cerebral atherosclerotic stenosis and coil products. The Structural Heart Disease Business segment includes Transcatheter Aortic Valve Implantation. The Surgical Robot Business segment includes the manufacture and R&D of surgical robot devices. The Surgical Devices Business segment includes the manufacture and R&D of surgical devices.
Employees
6,547
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - MicroPort Scientific Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.7750USD
Average target price
1.800USD
Spread / Average Target
+132.21%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - MicroPort Scientific Corporation